UroGen Pharma Ltd. Financial Ratios — URGN Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-9.15	-40.57	-84.48	-68.73	-79.22	-91.68	-85.98	-65.14	-54.68	-63.14
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	99.84	92.65	-59.84	100	91.45	89.27	88.11	88.68	90.18	88.66
EBITDA Margin (%)	- -	5.77	-242.01	-6,805.23	-600,855.56	-1,056.83	-188.42	-119.99	-77.17	-105.75	-111.53
Operating Margin (%)	- -	4.55	-244.55	-6,842.2	-608,211.11	-1,074.15	-192.11	-122.82	-79.23	-107.06	-113.73
Incremental Operating Margin (%)	- -	75.35	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-11.07	-244.93	-6,696.1	-584,144.44	-1,060.34	-227.66	-167.86	-118.87	-137.22	-139.74
Profit Margin (%)	- -	-11.07	-245.16	-6,707.18	-584,144.44	-1,088.94	-230.67	-170.58	-123.61	-140.35	-139.81
Net Income to Common Margin (%)	- -	-25.15	-255.27	-6,707.18	-584,144.44	-1,088.94	-230.67	-170.58	-123.61	-140.35	-139.81
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	6.29	55.97	3.96	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	3	1	- -	99	99	123	128
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	3	1	- -	99	99	123	128
Total Debt/EBITDA	- -	- -	- -	- -	-0.02	-0.01	- -	-1.28	-1.56	-1.29	-1.05
Net Debt/EBITDA	1.46	-21.13	1.87	1.32	0.46	0.42	0.49	-0.55	-0.06	0.53	-0.09
Total Debt/EBIT	- -	- -	- -	- -	-0.02	-0.01	- -	-1.25	-1.52	-1.27	-1.03
Net Debt/EBIT	1.45	-26.77	1.85	1.31	0.45	0.42	0.48	-0.53	-0.05	0.52	-0.09
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	-9.15	-4.34	-7.63	-7.98
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	-9.18	-4.35	-7.66	-8
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	-9.37	-4.45	-7.73	-8.14
Interest Expense	- -	- -	- -	- -	- -	- -	- -	8	15	13	15
Common Equity/Total Assets	-130.31	-118.01	-62.44	-118.61	-112.64	-292.15	-390.21	-425.49	-380.94	-282.14	-478.7
Long-Term Debt/Equity (%)	- -	- -	- -	- -	1.44	1.55	4.73	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-1.16	-0.42	-0.09	-20.74	-17.14	-18.07	-15.44
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	1.29	1.23	0.33	73.09	55.74	43.19	64.02
Total Debt/Equity (%)	- -	- -	- -	- -	1.44	1.55	4.73	-110.92	-152.42	-1,401.65	-121.67
Total Debt/Capital (%)	- -	- -	- -	- -	-1.16	-0.42	-0.09	-20.74	-17.14	-18.07	-15.44
Total Debt/Total Assets (%)	- -	- -	- -	- -	1.29	1.23	0.33	73.09	55.74	43.19	64.02
Net Debt to Equity	-110.4	-131	-54	-112.46	-27.56	-54.86	-527.28	-47.14	-5.44	570.86	-10.87
Net Debt/Capital (%)	41.58	43.99	43.95	45.2	18.07	12.96	8.68	-7.9	-0.53	5.88	-1.22
EBITDA	-12	1	-20	-77	-108	-125	-91	-77	-64	-96	-122
EBITDA-CapEx	-13	- -	-20	-77	-108	-126	-91	-77	-64	-96	-123
Operating Income (Loss)	-12	1	-20	-77	-109	-127	-92	-79	-66	-97	-125

Liquidity (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	8.04	6.81	10.38	7.52	7.55	4.76	3.98	4.18	4.39	5.15	2.6
Current Ratio	8.55	7.03	10.59	7.59	7.63	5.39	5.11	5.39	5.42	6.01	4.01
Quick Ratio	8.04	6.84	10.38	7.52	7.55	5.09	4.51	4.71	4.88	5.59	3.31
CFO/Avg Current Liab	- -	1.56	-1.88	-3.64	-4.31	-5.18	-3.87	-3.78	-2.77	-2.51	-3.52
Common Equity/Total Assets	-130.31	-118.01	-62.44	-118.61	-112.64	-292.15	-390.21	-425.49	-380.94	-282.14	-478.7
Long-Term Debt/Equity (%)	- -	- -	- -	- -	1.44	1.55	4.73	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-1.16	-0.42	-0.09	-20.74	-17.14	-18.07	-15.44
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	1.29	1.23	0.33	73.09	55.74	43.19	64.02
Total Debt/Equity (%)	- -	- -	- -	- -	1.44	1.55	4.73	-110.92	-152.42	-1,401.65	-121.67
Total Debt/Capital (%)	- -	- -	- -	- -	-1.16	-0.42	-0.09	-20.74	-17.14	-18.07	-15.44
Total Debt/Total Assets (%)	- -	- -	- -	- -	1.29	1.23	0.33	73.09	55.74	43.19	64.02
CFO/Total Liabilities	-230.78	62.07	-136.01	-277.27	-321.55	-412.81	-76.25	-38.92	-31.36	-32.86	-53.1
CFO/CapEx	-23.84	6.03	-35.31	-66.67	-218.51	-87.15	-112.89	-344.72	-393.69	-328.02	-562.09
Altman's Z-Score	-2.89	0.21	30.27	27.15	16.01	2.69	-5.54	-5.94	-4.09	-2.85	-5.16

Working Capital (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	422.41	196.58	- -	- -	3.35	5.12	5.27	5.88	5.06	4.11
Days Sales Outstanding	- -	0.86	1.86	- -	- -	109	71.28	69.25	62.1	72.16	88.74
Inventory Turnover	- -	0.53	2.85	11.41	- -	1.03	1.52	1.67	1.87	1.19	0.97
Days Inventory Outstanding	- -	684.38	128.05	31.99	- -	355.23	240.5	218.34	194.92	306.19	376.69
Accounts Payable Turnover	- -	0.07	0.34	0.42	- -	0.75	1.77	1.26	1.78	1.43	1.71
Accounts Payable Turnover Days	- -	4,950.83	1,061.92	872.74	- -	488.94	205.97	288.88	205.2	256.03	213.87
Cash Conversion Cycle	- -	-4,265.59	-932.01	-840.75	- -	-24.71	105.81	-1.29	51.82	122.32	251.55
Inventory to Cash Days	- -	-683.51	-126.2	-31.99	- -	-246.23	-169.22	-149.09	-132.81	-234.02	-287.95
Inventories	- -	- -	- -	- -	- -	2	5	4	6	9	16
Raw Materials	- -	- -	- -	- -	- -	1	3	2	3	5	11
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	1	2	2	3	5	5
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	362	678	685	392	213	202	433	457	1,127
- Cash & Cash Equivalents	18	21	37	101	50	53	44	55	95	172	111
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	3	1	- -	99	99	123	128
Enterprise Value	-18	-21	289	577	541	292	124	201	395	343	1,135
Total Capital	-25	-27	-47	-123	-225	-355	-467	-478	-580	-683	-831
Total Debt/Capital (%)	- -	- -	- -	- -	-1.16	-0.42	-0.09	-20.74	-17.14	-18.07	-15.44
Total Debt / EV	- -	- -	- -	- -	- -	0.01	- -	0.49	0.25	0.36	0.11
EV/Sales	- -	- -	35.37	511.58	30,031.7	24.75	2.58	3.13	4.77	3.8	10.34
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	362	678	685	392	213	202	433	457	1,127
Diluted Enterprise Value	-18	-21	325	577	638	341	169	246	437	408	1,144
EV per Share	- -	- -	29.7	36.63	26.33	13.4	5.54	8.83	13.7	8.01	23.58
TTM Sales	- -	18	8	1	- -	12	48	64	83	90	110
TTM EBITDA	-12	1	-20	-77	-108	-125	-91	-77	-64	-96	-122
TTM Operating Income	-12	1	-20	-77	-109	-127	-92	-79	-66	-97	-125
TTM Cash Flow to Firm	-7	4	-10	-37	-71	-106	-85	-79	-61	-84	-147
TTM Free Cash Flow to Firm	-7	5	-9	-37	-71	-105	-84	-79	-61	-84	-147

Multiples (USD)

API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-38.89	-18.45	-9.69	-3.75	-2.53	-2.32	-5.68	-4.73	-6.95
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-18	-21	289	577	541	292	124	201	395	343	1,135
Low Price	- -	- -	13.01	36.95	20.72	13.12	8.68	4.85	7.6	10.26	3.42
EV/Sales	- -	- -	35.37	511.58	30,031.7	24.75	2.58	3.13	4.77	3.8	10.34
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-12.14	-10.4	-6.76	-4.02	-3.48	-1.68	-3.48	-4.84	-4.73
Price/Earnings High	- -	- -	-20.82	-14.49	-10.83	-5.93	-5.69	-2.62	-6.81	-7	-9.4
Price/Earnings Low	- -	- -	-6.07	-7.69	-4.05	-2.22	-1.75	-1.01	-2.14	-3.47	-1.07
Price/Book Value	- -	- -	-7.66	-5.52	-3.01	-1.1	-0.45	-0.35	-0.64	-0.57	-1.17
Price/Book Value Average	- -	- -	-5.36	-6.41	-3.12	-1.45	-0.83	-0.32	-0.52	-0.76	-0.76
Price/Book Value High	- -	- -	-9.19	-8.92	-5	-2.14	-1.35	-0.5	-1.02	-1.1	-1.5
Price/Book Value Low	- -	- -	-2.68	-4.74	-1.87	-0.8	-0.42	-0.19	-0.32	-0.55	-0.17
Price/Tangible Book Value	- -	- -	5.28	7.53	3.8	4.07	25.26	-2.26	-6.63	-51.87	-10.68
Price/Tangible Book Value Average	- -	- -	3.69	8.74	3.94	5.37	45.86	-2.07	-5.45	-69.76	-6.88
Price/Tangible Book Value High	- -	- -	6.33	12.16	6.32	7.91	74.91	-3.22	-10.67	-100.82	-13.69
Price/Tangible Book Value Low	- -	- -	1.85	6.46	2.36	2.97	23.06	-1.24	-3.36	-49.97	-1.56
Price/Sales	- -	- -	44.32	601.4	38,057.98	33.26	4.42	3.14	5.23	5.05	10.26
Price/Sales Average	- -	- -	31	697.78	39,460.64	43.81	8.03	2.87	4.3	6.79	6.61
Price/Sales High	- -	- -	53.16	971.61	63,285.5	64.61	13.12	4.48	8.41	9.82	13.15
Price/Sales Low	- -	- -	15.5	516.06	23,630.85	24.22	4.04	1.72	2.65	4.87	1.5
Price/Cash Flow	- -	- -	-37.79	-18.17	-9.65	-3.71	-2.5	-2.31	-5.66	-4.72	-6.94
Price/Cash Flow Average	- -	- -	-26.43	-21.08	-10	-4.88	-4.55	-2.11	-4.66	-6.35	-4.47
Price/Cash Flow High	- -	- -	-45.32	-29.36	-16.04	-7.2	-7.42	-3.29	-9.11	-9.17	-8.89
Price/Cash Flow Low	- -	- -	-13.21	-15.59	-5.99	-2.7	-2.29	-1.26	-2.87	-4.55	-1.01
Price/Free Cash Flow Average	- -	- -	-27.2	-21.4	-10.05	-4.94	-4.59	-2.12	-4.67	-6.37	-4.48
Price/Free Cash Flow High	- -	- -	-46.65	-29.8	-16.11	-7.28	-7.49	-3.3	-9.13	-9.2	-8.9
Price/Free Cash Flow Low	- -	- -	-13.6	-15.83	-6.02	-2.73	-2.31	-1.27	-2.88	-4.56	-1.01
EV/Sales Average	- -	- -	26.46	607.96	36,844.86	39.46	7.12	3.55	4.35	6.26	6.77
EV/Sales High	- -	- -	48.62	881.79	60,669.73	60.26	12.2	5.16	8.46	9.28	13.31
EV/Sales Low	- -	- -	10.96	426.24	21,015.07	19.86	3.12	2.4	2.7	4.33	1.66
EV/EBITDA Average	1.46	-21.12	-10.93	-8.93	-6.13	-3.73	-3.78	-2.96	-5.64	-5.92	-6.07
EV/EBITDA High	1.46	-21.12	-20.09	-12.96	-10.1	-5.7	-6.48	-4.3	-10.97	-8.78	-11.93
EV/EBITDA Low	1.46	-21.12	-4.53	-6.26	-3.5	-1.88	-1.66	-2	-3.5	-4.09	-1.49
EV/EBIT Average	1.45	-26.75	-10.82	-8.89	-6.06	-3.67	-3.7	-2.89	-5.49	-5.84	-5.96
EV/EBIT High	1.45	-26.75	-19.88	-12.89	-9.98	-5.61	-6.35	-4.2	-10.68	-8.67	-11.7
EV/EBIT Low	1.45	-26.75	-4.48	-6.23	-3.46	-1.85	-1.63	-1.95	-3.41	-4.04	-1.46
Last Price	- -	- -	37.21	43.06	33.37	18.02	9.51	8.87	15	10.65	23.42
High Price	- -	- -	44.63	69.57	55.49	35	28.2	12.63	24.13	20.7	30
Enterprise Value Average	-18	-21	216	686	663	466	342	229	360	566	744
Enterprise Value High	-18	-21	397	995	1,092	711	586	332	700	839	1,461
Enterprise Value Low	-18	-21	89	481	378	234	150	154	224	391	182

Shares Outstanding	11	11	14	16	21	22	22	23	32	42	48
Diluted Weighted Avg Shares	12	12	10	16	21	22	22	23	29	43	48
Basic Weighted Avg Shares	12	12	10	16	21	22	22	23	29	43	48
Revenue per Share	- -	1.46	0.84	0.07	- -	0.54	2.15	2.82	2.87	2.11	2.28
EBITDA per Share	-1.03	0.08	-2.03	-4.87	-5.27	-5.72	-4.05	-3.39	-2.21	-2.23	-2.54
Operating Income per Share	-1.04	0.07	-2.05	-4.9	-5.33	-5.82	-4.13	-3.47	-2.27	-2.26	-2.6
Basic EPS, GAAP	-1.13	-0.37	-2.14	-4.8	-5.12	-5.9	-4.96	-4.81	-3.55	-2.96	-3.19
Basic EPS from Cont Ops	-1.06	-0.16	-2.06	-4.8	-5.12	-5.9	-4.96	-4.81	-3.55	-2.96	-3.19
Diluted EPS, GAAP	-1.13	-0.37	-2.14	-4.8	-5.12	-5.9	-4.96	-4.81	-3.55	-2.96	-3.19
Diluted EPS from Cont Ops	-1.06	-0.16	-2.06	-4.8	-5.12	-5.9	-4.96	-4.81	-3.55	-2.96	-3.19
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.6	0.35	-0.98	-2.37	-3.46	-4.86	-3.8	-3.84	-2.65	-2.26	-3.38
Free Cash Flow per Basic Share	-0.62	0.29	-1.01	-2.41	-3.48	-4.92	-3.83	-3.85	-2.66	-2.26	-3.38
Cash & Equivalents per Share	1.5	1.78	7.51	6.43	7.16	4.68	3.99	4.38	4.75	5.52	2.5
Book Value per Share	-2.11	-2.27	-4.86	-7.8	-11.1	-16.36	-20.91	-25.3	-23.56	-18.8	-19.94
Tangible Book Value per Share	1.36	1.36	7.05	5.72	8.78	4.42	0.38	-3.92	-2.26	-0.21	-2.19

UroGen Pharma Ltd.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)